MAGL-IN-15
MAGL-IN-15 (Compound 6) is a MAGL inhibitor that can be used in the research of diseases and disorders related to the regulation of endocannabinoid system signaling activities[1].
Product Specifications
CAS Number
[2770967-08-1]
UNSPSC
12352005
Target
MAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/magl-in-15.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1CC12CCN(C(OC(C(F)(F)F)C(F)(F)F)=O)CC2)NC3=CC=CN=N3
Molecular Formula
C16H16F6N4O3
Molecular Weight
426.31
References & Citations
[1]John J.M. Wiener, et al. Magl inhibitors. U.S. US20240018120A1. 2024-01-18
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
T8319-04A 200 µL
TRIAD3, CT (E3 Ubiquitin-protein Ligase RNF216, RING Finger Protein 216, Ubiquitin Conjugating Enzyme 7 Interacting Protein 1, Triad3 Protein, Zinc Finger Protein Inhibiting NF-kappa-B, Triad Domain-containing Protein 3, UBCE7IP1, RNF216, ZIN)
Ask
View Details 
